As of 2026-08-24, Encompass Health Corporation Common Stock (EHC) has a 3-month relative strength percentile of 75 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 52. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 2.3%, relative volume 0.73×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
EHC is held by 50 ETFs as of May 2026. Top owner: VHT at 0.17% weight, $32M notional. Top 3 carry $78M.
Held by 146 ETFs · $1.8B across latest filings · largest weight 3.34% (TSCM).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| VHTVanguard Health Care ETF | 0.17% | $32M | — |
| SCHMSchwab U.S. Mid-Cap ETF | 0.20% | $29M | −0.02 pp |
| IVOO | 0.30% | $17M | −0.01 pp |
| OUSM | 1.68% | $15M | −0.01 pp |
| SCHXSchwab U.S. Large-Cap ETF | 0.02% | $11M |
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| — |
| IVOG | 0.58% | $11M | −0.02 pp |
| XMLV | 1.08% | $8M | +0.09 pp |
| VONVVanguard Russell 1000 Value ETF | 0.03% | $7M | — |
| LRGC | 0.51% | $6M | — |
| SCHBSchwab U.S. Broad Market ETF | 0.01% | $6M | — |
Showing 10 of 50 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | EHC Jan avg: 1.86% median: 5.44% win: 75% σ: 8.63% n: 4 2022-04-12 → 2026-07-31 | EHC Feb avg: 2.56% median: 2.80% win: 75% σ: 9.77% n: 4 2022-04-12 → 2026-07-31 | EHC Mar avg: -0.62% median: -1.57% win: 50% σ: 9.05% n: 4 2022-04-12 → 2026-07-31 | EHC Apr avg: 6.81% median: 3.38% win: 80% σ: 9.82% n: 5 2022-04-12 → 2026-07-31 | EHC May avg: 0.94% median: 3.34% win: 60% σ: 4.69% n: 5 2022-04-12 → 2026-07-31 | EHC Jun avg: -1.81% median: -0.69% win: 40% σ: 8.66% n: 5 2022-04-12 → 2026-07-31 | EHC Jul avg: -0.83% median: -2.48% win: 40% σ: 9.59% n: 5 2022-04-12 → 2026-07-31 | EHC Aug avg: 3.56% median: 3.85% win: 75% σ: 6.71% n: 4 2022-04-12 → 2026-07-31 (current) | EHC Sep avg: -1.04% median: -0.80% win: 50% σ: 5.95% n: 4 2022-04-12 → 2026-07-31 | EHC Oct avg: 1.52% median: -1.97% win: 50% σ: 13.76% n: 4 2022-04-12 → 2026-07-31 | EHC Nov avg: 4.29% median: 3.84% win: 100% σ: 2.26% n: 4 2022-04-12 → 2026-07-31 | EHC Dec avg: -3.58% median: -3.20% win: 50% σ: 6.85% n: 4 2022-04-12 → 2026-07-31 |